Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 19/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9225871 | 1.00 | ALOX5 (0.54) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9222009 | 0.91 | ALOX5 (0.46) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9393736 | 0.91 | ALOX5 (0.46) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9228908 | 0.86 | ALOX5 (0.71) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9210920 | 0.83 | ALOX5 (0.52) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9226267 | 0.83 | ALOX5 (0.52) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9226271 | 0.83 | ALOX5 (0.52) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9229117 | 0.79 | ALOX5 (0.60) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9197677 | 0.77 | ALOX5 (0.37) | ALOX5PTGS2PTGS1 | |
| SCHEMBL9049332 | 0.77 | ALOX5 (0.37) | ALOX5PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5403859-A | PHENYLENE-CYCLIC ETHER COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1995-04-04 | — | — | US | disclosed |
| EP-0375404-B1 | Heterocyclic derivatives | ICI PLC (GB) | 1994-02-09 | — | — | EP | disclosed |
| US-5234950-A | Antiallergens, antiinflammatory agents; cardiovascular disorders, antiarthritic | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-08-10 | — | — | US | disclosed |